Home
Company
Product
Regulation
China
Data
Exhibition
Interview
中文版
Home
Company
Product
Regulation
China
Data
Exhibition
Interview
中文版
Search

BLVK Launches 20,000 Puff Disposable "BLVK Bar" Featuring 15 E-Liquid Flavors

Events by 2FIRSTS
Feb.01.2024
BLVK Launches 20,000 Puff Disposable "BLVK Bar" Featuring 15 E-Liquid Flavors
BLVK E-Liquid introduces BLVK Bar, a unique disposable e-cigarette with longer battery life and enhanced flavors.

According to a report by the American News Agency on January 31st, e-liquid brand BLVK E-Liquid has launched a line of 20,000 disposable e-cigarettes, known as the BLVK Bar.

 

Wilson Sun, CEO of BLVK E-liquid, has stated that the BLVK Bar aligns with the growing trend in the e-cigarette market of launching disposable vape pens, while also injecting a new element into the smoking experience. This unique vape pen stands out in the market with its extended battery life and exceptional e-liquid flavor, all at a competitive price compared to other brands.

 

The notable features of BLVK Bar include:

 

BLVK Bare-cigarette is equipped with an LED screen and comes with 15 types of e-liquid. It offers adjustable power modes with three power settings. The device features the NIO-X™ dual coil system, which allows for alternating ignition of two coils. It is made of Kanthal alloy material and utilizes an anti-flavor-burning technology. The device is powered by a rechargeable lithium iron battery, which can be charged up to 50% in just 25 minutes.

 

References:
[1] BLVK E-Liquid Introduces the BLVK Bar, the FIRST EVER 20,000 Puff Disposable Vape Device
Also Read:
[1] Future of UK E-cig Market: Pod System Brands Capitalizing on Disposable Ban
[2] SMISS: Large-Puff E-Cigarettes are the Mainstream in Dubai
#North America#United States#Disposable e-cigarettes#Products#E-cigarettes with Flavors

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Eleventh session of the Conference of the Parties (COP11) to the WHO FCTC
Eleventh session of the Conference of the Parties (COP11) to the WHO FCTC
FDA CTP Acting Director Supports Expanding Authorized Flavored E-Cigs and Legal Marketplace
FDA CTP Acting Director Supports Expanding Authorized Flavored E-Cigs and Legal Marketplace
At the FDLI Tobacco and Nicotine Policy Conference, FDA CTP Acting Director Bret Koplow spoke in favor of promoting tobacco harm reduction to reduce smoking. He backed a legal marketplace for authorized reduced-risk products, potential expansion of flavored e-cigs, and faster FDA reviews to ensure a strong, regulated market.
Oct.29 by 2FIRSTS.ai
France proposes tax on e-liquid in latest budget plan: 30 to 50 euro cents per 10 ml bottle
France proposes tax on e-liquid in latest budget plan: 30 to 50 euro cents per 10 ml bottle
France to introduce tax on e-cigarette liquid in new budget proposal, with rates ranging from 30 to 50 euro cents per 10ml.
Oct.15 by 2FIRSTS.ai
Newport News, Virginia, USA, has passed new regulations requiring new e-cigarette shops to be approximately 610 meters away from schools
Newport News, Virginia, USA, has passed new regulations requiring new e-cigarette shops to be approximately 610 meters away from schools
New zoning regulations in Newport News, Virginia require e-cigarette shops to be at least 2000 feet from schools and daycares.
Sep.25 by 2FIRSTS.ai
BAT Korea Announces Fall Promotion for glo™ hyper Series, Price Reductions up to 40%
BAT Korea Announces Fall Promotion for glo™ hyper Series, Price Reductions up to 40%
BAT Rothmans introduces "glo hyper" series promotion in South Korea, with "glo hyper pro" for $20 and "glo hyper" for $14.
Oct.15 by 2FIRSTS.ai
Product | Dual-flavor, 30,000-puff SKE 2-in-1 launches across multiple UK distributor platforms.
Product | Dual-flavor, 30,000-puff SKE 2-in-1 launches across multiple UK distributor platforms.
E-cigarette brand SKE has listed its “30K Pro Max” bundle across multiple UK e-commerce platforms. The 2-in-1 device features dual flavors with a twist-to-switch design, draw activation, and mesh heating, with a claimed total of up to 30,000 puffs. Across several channels, single-unit pricing ranges from about £8.99 to £10.99.
Oct.24 by 2FIRSTS.ai
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
Related Topics
News Product
Related Read
FDA CTP Acting Director Supports Expanding Authorized Flavored E-Cigs and Legal Marketplace
FDA CTP Acting Director Supports Expanding Authorized Flavored E-Cigs and Legal Marketplace
2FIRSTS.ai
France proposes tax on e-liquid in latest budget plan: 30 to 50 euro cents per 10 ml bottle
France proposes tax on e-liquid in latest budget plan: 30 to 50 euro cents per 10 ml bottle
2FIRSTS.ai
Newport News, Virginia, USA, has passed new regulations requiring new e-cigarette shops to be approximately 610 meters away from schools
Newport News, Virginia, USA, has passed new regulations requiring new e-cigarette shops to be approximately 610 meters away from schools
2FIRSTS.ai
BAT Korea Announces Fall Promotion for glo™ hyper Series, Price Reductions up to 40%
BAT Korea Announces Fall Promotion for glo™ hyper Series, Price Reductions up to 40%
2FIRSTS.ai
Product | Dual-flavor, 30,000-puff SKE 2-in-1 launches across multiple UK distributor platforms.
Product | Dual-flavor, 30,000-puff SKE 2-in-1 launches across multiple UK distributor platforms.
2FIRSTS.ai
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
2FIRSTS.ai
FOLLOW US ON SOCIAL MEDIA
Contact: info@2firsts.com
Stay up to date.
Submit your email to receive weekly newsletter on the most relevant news of the e-cigarette industry.
© 2025 Shenzhen 2FIRSTS Technology Co.,Ltd. All Right Reserved.
2FIRSTS is only accessible to industry practitioners, researchers, media and other professionals. Access by minors is prohibited.
This website provides services to users outside the Chinese mainland. For Chinese mainland users, please visit https://cn.2firsts.com
English
English
中文